Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy

MLA

Winson Y. Cheung, et al. “Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-Line Chemotherapy.” American Journal of Clinical Oncology, vol. 44, Aug. 2021, pp. 519–25. EBSCOhost, https://doi.org/10.1097/coc.0000000000000856.

APA

Winson Y. Cheung, Patricia A. Tang, & Atul Batra. (2021). Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. American Journal of Clinical Oncology, 44, 519–525. https://doi.org/10.1097/coc.0000000000000856

Chicago

Winson Y. Cheung, Patricia A. Tang, and Atul Batra. 2021. “Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-Line Chemotherapy.” American Journal of Clinical Oncology 44 (August): 519–25. doi:10.1097/coc.0000000000000856.